Caris Life Sciences
CAI
27.10
-0.36
-1.29%
Caris Life Sciences
US · CAI
#1669 by market cap
Listed 2025
27.10
-0.36
-1.29%
Live - 5344 symbols - heartbeat 221s ago
· 2026-10-08 07:00
Pre-market
26.80
-1.11%
After-hours
27.10
0.00%
Overnight
26.88
-0.81%
- Market cap
- 7.66B
- P/E (TTM)i
- 72.85
- P/Bi
- 12.94
- EPSi
- -1.90
- Div yieldi
- 0.00%
- 52W posi
- 66%
Reader sentiment
Are you bullish or bearish on CAI?
Anonymous reader poll. Unscientific, not investment advice.
About Caris Life Sciences
Caris Life Sciences, Inc. is a leading patient-centered next-generation artificial intelligence technology biology company and precision medicine pioneer. It develops and commercializes innovative solutions to transform health care through the large-scale use of comprehensive molecular information and AI/ML algorithms. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology and serving the clinical, academic and biopharmaceutical markets.
- Founded
- 2008
- CEO
- Mr. David Dean Halbert, D.Sc.
- Employees
- 1,769
- Headquarters
- Irving, Texas, United States of America
- Fiscal year end
- 12-31
- Website
- carislifesciences.com
Company profile
- Exchange
- US
- Symbol
- CAI
- Market-cap rank
- #1669
- Listing date
- 2025-06-18
- Market cap
- 7.66B
- Float cap
- 3.14B
- Shares out
- 282.60M
- Float shares
- 115.84M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-10-08 07:00:15 · For reference only, not investment advice and not tailored to your situation.